Current OAG News

IBD Consensus Document

Ontario Association of Gastroenterologists Consensus Statement on the Ontario Reimbursement Criteria for Biologic Therapies in Inflammatory Bowel Disease

The Ontario Association of Gastroenterologists (OAG) and the Ontario Public Drug Plan (OPDP) have a common goal of providing excellence in health care to patients living with inflammatory bowel disease (IBD). With this in mind, the OAG formed a consensus group to review the current Exceptional Access Program (EAP) reimbursement criteria (updated August 1, 2015) for the use of biologic therapies in IBD in Ontario. Taking into consideration recent treatment guidelines and the most robust clinical data for all available therapies, this group developed several recommendations that will further align the EAP criteria with current evidence.



Ontario Association of Gastroenterology Consensus Group:
Statement on the Introduction of Subsequent Entry Biologics in Canada

The introduction of subsequent entry biologic (SEB) therapies provides an important opportunity to increase treatment options for both patients and providers and to improve the collective affordability of biologic agents. However, the complex structures of SEBs make generation of biologically identical molecules a challenge (Devlin et al., 2013), and even subtle differences between SEBs and innovators may translate into clinically relevant variations in efficacy, safety, and immunogenicity. Such variations are of significant concern to the Ontario Association of Gastroenterologists (OAG) and several other groups (eg, the Canadian Association of Gastroenterologists [CAG]) (Devlin et al., 2013; Endrenyi et al., 2014), as patients with inflammatory bowel disease (IBD) represent a very sick and vulnerable patient population. 


Press Release:

OAG's Response to Task Force Recommendations on Colon Cancer Screening

TORONTO, ON – (February 29, 2016) - The Ontario Association of Gastroenterology (OAG) believes that “Colonoscopy is probably the best colon cancer screening test, it's just not proven yet,” according to OAG President Dr. Iain Murray.  “The OAG is concerned that a recent report is being understood as saying ‘don’t do colonoscopies’, and that’s an incorrect understanding,” Murray states. He adds that colonoscopies promote prevention of cancer, thus supporting the current emphasis in health care on overall wellness, and not just treatment.